Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model

Local recurrence of colorectal cancer (CRC) can occur in patients after curative resection, and additional surgical resection may therefore be required; however, this is a significant burden for patients, because additional surgical resection may necessitate the resection of other organs such as the...

Full description

Bibliographic Details
Main Authors: Jun Arima, Kohei Taniguchi, Masashi Yamamoto, Tsubasa Watanabe, Yusuke Suzuki, Hiroki Hamamoto, Yosuke Inomata, Hideki Kashiwagi, Shinji Kawabata, Keitaro Tanaka, Kazuhisa Uchiyama, Minoru Suzuki, Sang-Woong Lee
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222010216
_version_ 1811273768502296576
author Jun Arima
Kohei Taniguchi
Masashi Yamamoto
Tsubasa Watanabe
Yusuke Suzuki
Hiroki Hamamoto
Yosuke Inomata
Hideki Kashiwagi
Shinji Kawabata
Keitaro Tanaka
Kazuhisa Uchiyama
Minoru Suzuki
Sang-Woong Lee
author_facet Jun Arima
Kohei Taniguchi
Masashi Yamamoto
Tsubasa Watanabe
Yusuke Suzuki
Hiroki Hamamoto
Yosuke Inomata
Hideki Kashiwagi
Shinji Kawabata
Keitaro Tanaka
Kazuhisa Uchiyama
Minoru Suzuki
Sang-Woong Lee
author_sort Jun Arima
collection DOAJ
description Local recurrence of colorectal cancer (CRC) can occur in patients after curative resection, and additional surgical resection may therefore be required; however, this is a significant burden for patients, because additional surgical resection may necessitate the resection of other organs such as the bladder, prostate, uterus, or sacral bone. Therefore, there is a need for alternative therapeutic strategies. We focused on boron neutron capture therapy (BNCT) as a treatment modality that can selectively target tumor cells without excessive damage to normal tissues. The usefulness of BNCT to pelvic CRC remains unknown. This study investigated the anti-cancer effect of boronophenylalanine (BPA)-mediated BNCT in a previously established mouse model of pelvic recurrence of CRC. Uptake of BPA in CRC was observed both in vitro and in vivo, and the concentrations were sufficient for BNCT. Our results are the first to show that BPA-mediated BNCT prolonged the survival of experimental mice with pelvic tumors; moreover, it did not cause any obvious severe side effects in the treated animals. In conclusion, BPA-mediated BNCT could contribute to treating local recurrence of pelvic CRC.
first_indexed 2024-04-12T23:05:19Z
format Article
id doaj.art-fecb0421e4274fea8e627e7461d750f7
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-12T23:05:19Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-fecb0421e4274fea8e627e7461d750f72022-12-22T03:12:56ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-10-01154113632Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse modelJun Arima0Kohei Taniguchi1Masashi Yamamoto2Tsubasa Watanabe3Yusuke Suzuki4Hiroki Hamamoto5Yosuke Inomata6Hideki Kashiwagi7Shinji Kawabata8Keitaro Tanaka9Kazuhisa Uchiyama10Minoru Suzuki11Sang-Woong Lee12Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanTranslational Research Program, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, Japan; Corresponding author.Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of Particle Radiation Oncology, Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro- Nishi, Kumatori-cho, Sennan-gun, Osaka 590–0494, JapanDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanDepartment of Particle Radiation Oncology, Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro- Nishi, Kumatori-cho, Sennan-gun, Osaka 590–0494, JapanDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2–7 Daigaku-machi, Takatsuki, Osaka 569–8686, JapanLocal recurrence of colorectal cancer (CRC) can occur in patients after curative resection, and additional surgical resection may therefore be required; however, this is a significant burden for patients, because additional surgical resection may necessitate the resection of other organs such as the bladder, prostate, uterus, or sacral bone. Therefore, there is a need for alternative therapeutic strategies. We focused on boron neutron capture therapy (BNCT) as a treatment modality that can selectively target tumor cells without excessive damage to normal tissues. The usefulness of BNCT to pelvic CRC remains unknown. This study investigated the anti-cancer effect of boronophenylalanine (BPA)-mediated BNCT in a previously established mouse model of pelvic recurrence of CRC. Uptake of BPA in CRC was observed both in vitro and in vivo, and the concentrations were sufficient for BNCT. Our results are the first to show that BPA-mediated BNCT prolonged the survival of experimental mice with pelvic tumors; moreover, it did not cause any obvious severe side effects in the treated animals. In conclusion, BPA-mediated BNCT could contribute to treating local recurrence of pelvic CRC.http://www.sciencedirect.com/science/article/pii/S0753332222010216Boron neutron capture therapyColorectal cancerPelvic recurrenceBoronophenylalanine
spellingShingle Jun Arima
Kohei Taniguchi
Masashi Yamamoto
Tsubasa Watanabe
Yusuke Suzuki
Hiroki Hamamoto
Yosuke Inomata
Hideki Kashiwagi
Shinji Kawabata
Keitaro Tanaka
Kazuhisa Uchiyama
Minoru Suzuki
Sang-Woong Lee
Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
Biomedicine & Pharmacotherapy
Boron neutron capture therapy
Colorectal cancer
Pelvic recurrence
Boronophenylalanine
title Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
title_full Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
title_fullStr Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
title_full_unstemmed Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
title_short Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
title_sort anti tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
topic Boron neutron capture therapy
Colorectal cancer
Pelvic recurrence
Boronophenylalanine
url http://www.sciencedirect.com/science/article/pii/S0753332222010216
work_keys_str_mv AT junarima antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT koheitaniguchi antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT masashiyamamoto antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT tsubasawatanabe antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT yusukesuzuki antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT hirokihamamoto antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT yosukeinomata antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT hidekikashiwagi antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT shinjikawabata antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT keitarotanaka antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT kazuhisauchiyama antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT minorusuzuki antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel
AT sangwoonglee antitumoreffectofboronneutroncapturetherapyinpelvichumancolorectalcancerinamousemodel